The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide Analogs.
Murai K, Hikita H, Yamada R, Nishimura Y, Miyazaki M, Ishida H, Hosui A, Sakamori R, Tatsumi N, Ohkawa K, Doi Y, Nawa T, Egawa S, Yoshida Y, Nozaki Y, Imanaka K, Nakahara M, Sakakibara M, Yakushijin T, Ogawa H, Usui T, Matsumoto K, Oze T, Kuriki S, Sometani E, Sung J, Shimoda A, Shigeno S, Maesaka K, Shirai K, Doi A, Tahata Y, Saito Y, Kodama T, Tatsumi T, Yamada T, Takehara T.
Murai K, et al. Among authors: hosui a.
Hepatol Res. 2025 Sep;55(9):1228-1238. doi: 10.1111/hepr.14225. Epub 2025 Jun 16.
Hepatol Res. 2025.
PMID: 40522439